Detalhe da pesquisa
1.
From pixels to patient care: deep learning-enabled pathomics signature offers precise outcome predictions for immunotherapy in esophageal squamous cell cancer.
J Transl Med
; 22(1): 195, 2024 Feb 22.
Artigo
Inglês
| MEDLINE | ID: mdl-38388379
2.
Outcome-Supervised Deep Learning on Pathologic Whole Slide Images for Survival Prediction of Immunotherapy in Patients with Non-Small Cell Lung Cancer.
Mod Pathol
; 36(8): 100208, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37149222
3.
Deep Learning With an Attention Mechanism for Differentiating the Origin of Brain Metastasis Using MR images.
J Magn Reson Imaging
; 58(5): 1624-1635, 2023 11.
Artigo
Inglês
| MEDLINE | ID: mdl-36965182
4.
Pneumonitis with combined immune checkpoint inhibitors and chemoradiotherapy in locally advanced non-small-cell lung cancer: a systematic review and meta-analysis.
Future Oncol
; 19(16): 1151-1160, 2023 May.
Artigo
Inglês
| MEDLINE | ID: mdl-37293787
5.
Update of latest data for combined therapy for esophageal cancer using radiotherapy and immunotherapy: A focus on efficacy, safety, and biomarkers.
Chin J Cancer Res
; 35(5): 483-500, 2023 Oct 30.
Artigo
Inglês
| MEDLINE | ID: mdl-37969961
6.
Genome-wide DNA methylation signature predict clinical benefit of bevacizumab in non-small cell lung cancer.
BMC Cancer
; 22(1): 828, 2022 Jul 29.
Artigo
Inglês
| MEDLINE | ID: mdl-35906610
7.
Local therapy combined with chemotherapy versus chemotherapy for postoperative oligometastatic non-small-cell lung cancer.
Future Oncol
; 15(14): 1593-1603, 2019 May.
Artigo
Inglês
| MEDLINE | ID: mdl-30855987
8.
Prognostic value of dynamic albumin-to-alkaline phosphatase ratio in limited stage small-cell lung cancer.
Future Oncol
; 15(9): 995-1006, 2019 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-30644319
9.
The Prognostic Value of TP53 Alteration in Patients with Head and Neck Squamous Cell Carcinoma Receiving Immunotherapy.
Oncologist
; 27(7): e604-e605, 2022 07 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35536754
10.
East Asian patients who received immunotherapy-based therapy associated with improved survival benefit in advanced non-small cell lung cancer: An updated meta-analysis.
Cancer Med
; 13(4): e7080, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38457254
11.
Efficacy and safety of thoracic radiotherapy in extensive-stage small-cell lung cancer patients receiving first-line immunotherapy plus chemotherapy: a propensity score matched multicentre retrospective analysis.
Radiat Oncol
; 19(1): 25, 2024 Feb 27.
Artigo
Inglês
| MEDLINE | ID: mdl-38413988
12.
Effect of longitudinal changes of cachexia on the efficacy and toxicity of immune checkpoint inhibitors in esophageal squamous cell cancer (ESCC) patients.
Nutrition
; 124: 112462, 2024 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-38663128
13.
Development and Validation of Nomograms for Predicting Pneumonia in Patients with COVID-19 and Lung Cancer.
J Inflamm Res
; 17: 3671-3683, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38867842
14.
Integrated multi-dimensional deep neural network model improves prognosis prediction of advanced NSCLC patients receiving bevacizumab.
Front Oncol
; 13: 1052147, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36865790
15.
Integrating Preoperative Computed Tomography and Clinical Factors for Lymph Node Metastasis Prediction in Esophageal Squamous Cell Carcinoma by Feature-Wise Attentional Graph Neural Network.
Int J Radiat Oncol Biol Phys
; 116(3): 676-689, 2023 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36641040
16.
Comparison of the Incidence Rate of Radiation Pneumonitis Observed in Patients with Advanced Lung Adenocarcinoma Treated with Simultaneous Thoracic Radiotherapy and 1G/2G/3G EGFR-TKIs.
Cancer Manag Res
; 15: 351-362, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37077536
17.
NcRNAs-mediated P2RX1 expression correlates with clinical outcomes and immune infiltration in patients with breast invasive carcinoma.
Aging (Albany NY)
; 14(10): 4471-4485, 2022 05 18.
Artigo
Inglês
| MEDLINE | ID: mdl-35585027
18.
Association between immune-related adverse events and the efficacy of PD-1 inhibitors in advanced esophageal cancer.
Front Immunol
; 13: 931429, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36248782
19.
Three models that predict the efficacy of immunotherapy in Chinese patients with advanced non-small cell lung cancer.
Cancer Med
; 10(18): 6291-6303, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34390218
20.
Toxicity Profile of Combining PD-1/PD-L1 Inhibitors and Thoracic Radiotherapy in Non-Small Cell Lung Cancer: A Systematic Review.
Front Immunol
; 12: 627197, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33859637